Takayasu Arteritis: Efficacy and Safety of Tocilizumab vs Placebo
Tocilizumab therapy improves time to relapse in Takayasu arteritis with a favorable safety and tolerability profile.
Large Vessel Vasculitis Imaging: Recommendations for Clinical Practice
EULAR has released 12 evidence-based recommendations for the use of imaging in the diagnosis and monitoring of large vessel vasculitis, including giant cell arteritis and Takayasu arteritis.
First Treatment for Eosinophilic Granulomatosis With Polyangiitis Approved by FDA
The FDA has expanded the approval of mepolizumab for treating eosinophilic granulomatosis with polyangiitis, which causes vasculitis.
Azathioprine With Glucocorticoids in Nonsevere Systemic Necrotizing Vasculitides
Adding azathioprine to glucocorticoids has no significant benefit for patients with nonsevere systemic necrotizing vasculitides.
Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Biomarkers Identified
Several circulating biomarkers for antineutrophil cytoplasmic antibody-associated vasculitis disease activity and organ involvement were identified using targeted serum proteomics.
Pulmonary Involvement in Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis
Central airway disease and a nodular pattern of pulmonary involvement occurred significantly more often in PR3-ANCA-positive patients than in MPO-ANCA-positive patients.
Increased Cardiovascular Risk Factor Prevalence in Takayasu's Arteritis
The risk for cardiovascular events was higher in patients with Takayasu's arteritis.
FDA Approves First Drug to Specifically Treat Giant Cell Arteritis
Actemra (tocilizumab) has been FDA-approved for its use in giant cell arteritis treatment.
FDA Gives Tocilizumab Priority Review Status for Giant Cell Arteritis
FDA will fast track review of nonsteroidal treatment option for giant cell arteritis.
Increased VTE Risk in GCA With and Without Glucocorticoids
Patients experienced an elevated risk of venous thromboembolism both immediately before and immediately after giant cell arteritis diagnosis.
Rheumatology Advisor Articles
- FDA Advisory Committee Recommends Against Approval of Baricitinib at Higher Dose for RA
- Subgingival Microbiome Profiles Similar in Established Rheumatoid Arthritis and Osteoarthritis
- Precision Medicine in Rheumatology: Personalizing Treatment for Improved Clinical Outcomes
- Rheumatoid Arthritis Linked to Subclinical Myocardial Dysfunction
- Quality of SLE Care Assessed in Specialized Lupus vs General Rheumatology Clinic
- EULAR Releases Recommendations for Managing Behcet Syndrome
- USPSTF Issues Recommendation for Vitamin D, Calcium Supplementation for Fracture Prevention
- Etanercept Monotherapy vs Combination Therapy Examined in Psoriatic Arthritis
- Precision Medicine in Rheumatology: Personalizing Treatment for Improved Clinical Outcomes
- Ultrasound Synovitis Detection Predicts Loss of Remission in Rheumatoid Arthritis
- Zilretta Benefits 'Real-World' Patients With Knee OA, Says Study
- Examining Unmet Needs of Joint Disease Associated With Calcium Pyrophosphate Crystal Deposition
- Decreased Muscle Performance Linked to Increased Disease Activity in Rheumatoid Arthritis
- ACP: Shifting Focus to Social Determinants of Health Can Improve Patient Care
- Lupus Is a Leading Cause of Death in Young Women